• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Miracor secures $10 million in series B | Funding Roundup

Miracor secures $10 million in series B | Funding Roundup

September 14, 2011 By MassDevice staff

Miracor

Private medical device company, Miracor Medical Systems GmbH, secured $10 million in the first closing of the series B financing round. Second closing is pending approval by investors.

Austria Wirtschaftsservice and German venture capital investment group SHS Gesellschaft für Beteiligungsmanagement joined existing investors, Earlybird and Delta Partners, to support Miracor’s financing round.

Sign up to get our free newsletters delivered right to your inbox.

"We are very pleased that we now can focus on the clinical trials to document the positive effects of our technology," Jon Hoem, Miracor CEO said in a prepared statement. "With the strong investor syndicate backing Miracor we have a unique opportunity to bring our product offering to the patients who need additional care after a heart attack."

Miracor is focusing on its Pressure-controlled Intermittent Coronary Sinus Occlusion System (PISCO), designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.  The technology has the potential to restore the function of muscle tissue following heart attacks or heart failure, according to Miracor.

Since its inception, the company has secured a total of $21.3 million in venture capital and grants to develop its pipeline.

Funding

Here’s a roundup of other dealflow and investment news:

  • Cardica secures $4 million note purchase
  • Valeritas completes $150 million in series C

  • Filed Under: News Well, Wall Street Beat Tagged With: dextera, Miracor, Regulatory Roundup, Valeritas

    In case you missed it

    • Technical Brief – “Understanding the Extensive OEM Benefits of Total Linear Motion Solutions.”
    • Exactech launches total hip arthroplasty system
    • Lensar announces first patients treated with Ally adaptive cataract treatment
    • HeartBeam submits heart attack diagnostic platform for FDA 510(k) clearance
    • GE Healthcare leads AliveCor Series F funding for ECG tech
    • New FDA ruling may lower costs for over-the-counter hearing aids
    • Data supports Sight Sciences’ Omni surgical system for glaucoma
    • Integra founder Richard Caruso has died
    • Moximed raises $40M for implantable shock absorber for knee osteoarthritis
    • Philips names Roy Jakobs as CEO amid ventilator, CPAP recalls
    • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
    • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
    • Outset Medical wins national VA contract
    • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
    • Abbott will spend $450M to up FreeStyle Libre production in Ireland
    • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
    • ResMed expects steady growth over the next year

    RSS From Medical Design & Outsourcing

    • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
      Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
    • Senators seek post-market FDA study of pulse oximeters and skin color
      Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
    • TE Connectivity opens global medical device prototyping center in Ireland
      TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
    • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
      Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
    • What’s next for Jennifer Fried after leaving Explorer Surgical?
      Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
    • The 24 best medical device innovations of 2022
      The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
    • FDA issues new COVID-19 testing guidance to avoid false negatives
      COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
    • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
      Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
    • FDA’s breakthrough medical device designations tally nears 700
      Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
    • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
      Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
    • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
      MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]

    Leave a Reply

    You must be logged in to post a comment.

    Primary Sidebar

    DeviceTalks Weekly

    August 12, 2022
    DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
    See More >

    MEDTECH 100 INDEX

    Medtech 100 logo
    Market Summary > Current Price
    The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
    Need Medtech news in a minute?
    We Deliver!

    MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

    MDO ad

    Footer

    MASSDEVICE MEDICAL NETWORK

    DeviceTalks
    Drug Delivery Business News
    Medical Design & Outsourcing
    Medical Tubing + Extrusion
    Drug Discovery & Development
    Pharmaceutical Processing World
    MedTech 100 Index
    R&D World
    Medical Design Sourcing

    DeviceTalks Webinars, Podcasts, & Discussions

    Attend our Monthly Webinars
    Listen to our Weekly Podcasts
    Join our DeviceTalks Tuesdays Discussion

    MASSDEVICE

    Subscribe to MassDevice E-Newsletter
    Advertise with us
    About
    Contact us
    Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

    Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
    The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

    Advertise | Privacy Policy